{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:56Z","timestamp":1787020556242,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07612-x","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:35:33Z","timestamp":1769247333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Critical evaluation of compositions and clinical relevance of Wharton\u2019s jelly-derived biologics"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7287-0335","authenticated-orcid":false,"given":"Annette M.","family":"Marleau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelynn R.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erendira","family":"Olvera Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Guerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"7","key":"7612_CR1","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/sctm.16-0492","volume":"6","author":"JE Davies","year":"2017","unstructured":"Davies JE, Walker JT, Keating A. Concise review: Wharton\u2019s jelly: the rich, but enigmatic, source of mesenchymal stromal cells. Stem Cells Transl Med. 2017;6(7):1620\u201330.","journal-title":"Stem Cells Transl Med"},{"key":"7612_CR2","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.ejogrb.2009.02.024","volume":"144 Suppl 1","author":"VL Ferguson","year":"2009","unstructured":"Ferguson VL, Dodson RB. Bioengineering aspects of the umbilical cord. Eur J Obstet Gynecol Reprod Biol. 2009;144 Suppl 1:S108\u201313.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7612_CR3","doi-asserted-by":"publisher","first-page":"1211217","DOI":"10.3389\/fcell.2023.1211217","volume":"11","author":"H Drobiova","year":"2023","unstructured":"Drobiova H, et al. Wharton\u2019s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications. Front Cell Dev Biol. 2023;11:1211217.","journal-title":"Front Cell Dev Biol"},{"key":"7612_CR4","doi-asserted-by":"publisher","first-page":"118570","DOI":"10.1016\/j.biopha.2025.118570","volume":"192","author":"T Gornicki","year":"2025","unstructured":"Gornicki T, et al. Wharton\u2019s jelly mesenchymal stem cells (WJ-MSCs), a \u201choly grail\u201d in tissue bioengineering and reconstructive medicine. Biomed Pharmacother. 2025;192:118570.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"7612_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000244392","volume":"71","author":"K Sobolewski","year":"1997","unstructured":"Sobolewski K, et al. Collagen and glycosaminoglycans of Wharton\u2019s jelly. Biol Neonate. 1997;71(1):11\u201321.","journal-title":"Biol Neonate"},{"key":"7612_CR6","doi-asserted-by":"crossref","unstructured":"Main BJ, et al. Umbilical Cord-Derived Wharton\u2019s jelly for regenerative medicine applications: a systematic review. Pharmaceuticals (basel). 2021;14(11).","DOI":"10.3390\/ph14111090"},{"issue":"10","key":"7612_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S1357-2725(03)00128-6","volume":"35","author":"T Gogiel","year":"2003","unstructured":"Gogiel T, Bankowski E, Jaworski S. Proteoglycans of Wharton\u2019s jelly. Int J Biochem Cell Biol. 2003;35(10):1461\u201369.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"7612_CR8","doi-asserted-by":"publisher","first-page":"2400335","DOI":"10.1002\/smsc.202400335","volume":"5","author":"DH Ramos-Rodriguez","year":"2025","unstructured":"Ramos-Rodriguez DH, Leach JK. Decellularized cell-secreted extracellular matrices as biomaterials for tissue engineering. Small Sci. 2025;5(2):2400335.","journal-title":"Small Sci"},{"issue":"3","key":"7612_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","volume":"26","author":"DL Troyer","year":"2008","unstructured":"Troyer DL, Weiss ML. Wharton\u2019s jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26(3):591\u201399.","journal-title":"STEM Cells"},{"issue":"2","key":"7612_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/scd.2017.0029","volume":"27","author":"R Donders","year":"2018","unstructured":"Donders R, et al. Human Wharton\u2019s jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compared to bone marrow-derived stem cells. Stem Cells Dev. 2018;27(2):65\u201384.","journal-title":"STEM Cells Dev"},{"issue":"2","key":"7612_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00418-008-0519-3","volume":"131","author":"G La Rocca","year":"2009","unstructured":"La Rocca G, et al. Isolation and characterization of oct-4+\/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2009;131(2):267\u201382.","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"7612_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u201317.","journal-title":"Cytotherapy"},{"issue":"6","key":"7612_CR13","doi-asserted-by":"publisher","first-page":"11692","DOI":"10.3390\/ijms140611692","volume":"14","author":"DW Kim","year":"2013","unstructured":"Kim DW, et al. Wharton\u2019s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013;14(6):11692\u2013712.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"7612_CR14","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","volume":"26","author":"ML Weiss","year":"2008","unstructured":"Weiss ML, et al. Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells. Stem Cells. 2008;26(11):2865\u201374.","journal-title":"STEM Cells"},{"issue":"5","key":"7612_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s13770-023-00538-9","volume":"20","author":"P Huang","year":"2023","unstructured":"Huang P, et al. Comparison of biological characteristics of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells from extremely preterm and term infants. Tissue Eng Regen Med. 2023;20(5):725\u201337.","journal-title":"Tissue Eng Regen Med"},{"issue":"2","key":"7612_CR16","doi-asserted-by":"publisher","first-page":"e9016","DOI":"10.1371\/journal.pone.0009016","volume":"5","author":"SJ Prasanna","year":"2010","unstructured":"Prasanna SJ, et al. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 2010;5(2):e9016.","journal-title":"PLoS One"},{"issue":"5","key":"7612_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3727\/096368910X536473","volume":"20","author":"T Deuse","year":"2011","unstructured":"Deuse T, et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transpl. 2011;20(5):655\u201367.","journal-title":"Cell Transpl"},{"issue":"1","key":"7612_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-019-1398-3","volume":"10","author":"KS Park","year":"2019","unstructured":"Park KS, et al. Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2019;10(1):288.","journal-title":"STEM Cell Res Ther"},{"key":"7612_CR19","doi-asserted-by":"crossref","unstructured":"Vizoso FJ, et al. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9).","DOI":"10.3390\/ijms18091852"},{"key":"7612_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2024.05.004","volume":"70","author":"CM Trigo","year":"2025","unstructured":"Trigo CM, et al. Mesenchymal stem cell secretome for regenerative medicine: where do we stand? J Adv Res. 2025;70:103\u201324.","journal-title":"J Adv Res"},{"issue":"4","key":"7612_CR21","first-page":"233","volume":"16","author":"W Widowati","year":"2024","unstructured":"Widowati W, et al. The potential of human Wharton\u2019s jelly mesenchymal stem cells secretome based topical gel for therapeutic application. Avicenna J Med Biotechnol. 2024;16(4):233\u201343.","journal-title":"Avicenna J Med Biotechnol"},{"issue":"3","key":"7612_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00418-024-02292-y","volume":"162","author":"YB Aw","year":"2024","unstructured":"Aw YB, et al. Development and functional testing of a novel in vitro delayed scratch closure assay. Histochem Cell Biol. 2024;162(3):245\u201355.","journal-title":"Histochem Cell Biol"},{"issue":"5","key":"7612_CR23","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1111\/iwj.70033","volume":"22","author":"JS Chin","year":"2025","unstructured":"Chin JS, et al. Secretome from prolonged high-density human Wharton\u2019s jelly stem cell culture accelerates wound healing in both in vitro and in vivo models. Int Wound J. 2025;22(5):e70033.","journal-title":"Int Wound J"},{"issue":"5","key":"7612_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/011573403X372908250117092252","volume":"21","author":"E Kwiecien","year":"2025","unstructured":"Kwiecien E, et al. Umbilical cord matrix (Wharton jelly) mesenchymal stem cells in Next-generation myocardial repair and regeneration: mechanisms and pre-clinical evidence. Curr Cardiol Rev. 2025;21(5):76\u2013103.","journal-title":"Curr Cardiol Rev"},{"issue":"1\u20132","key":"7612_CR25","first-page":"1","volume":"34","author":"A Ghamrawi","year":"2025","unstructured":"Ghamrawi A, et al. Wharton\u2019s jelly mesenchymal stem cells: shaping the future of osteoarthritis therapy with advancements in chitosan-hyaluronic acid scaffolds. Stem Cells Dev. 2025;34(1\u20132):1\u201316.","journal-title":"STEM Cells Dev"},{"issue":"1","key":"7612_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/bmb\/ldad030","volume":"149","author":"A Aratikatla","year":"2024","unstructured":"Aratikatla A, et al. Wharton\u2019s jelly and osteoarthritis of the knee. Br Med Bull. 2024;149(1):13\u201331.","journal-title":"Br Med Bull"},{"issue":"5","key":"7612_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s12015-022-10344-w","volume":"18","author":"S Kannan","year":"2022","unstructured":"Kannan S, et al. Characteristics of pooled Wharton\u2019s jelly mesenchymal stromal cells (WJ-MSCs) and their potential role in rheumatoid arthritis treatment. Stem Cell Rev Rep. 2022;18(5):1851\u201364.","journal-title":"STEM Cell Rev Rep"},{"issue":"5","key":"7612_CR28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/jcmm.17105","volume":"26","author":"C Pochon","year":"2022","unstructured":"Pochon C, et al. Wharton\u2019s jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation. J Cell Mol Med. 2022;26(5):1339\u201350.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"7612_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ph8020196","volume":"8","author":"JP McGuirk","year":"2015","unstructured":"McGuirk JP, et al. Wharton\u2019s jelly-derived mesenchymal stromal cells as a promising cellular therapeutic strategy for the management of graft-versus-host disease. Pharmaceuticals (basel). 2015;8(2):196\u2013220.","journal-title":"Pharmaceuticals (basel)"},{"issue":"2","key":"7612_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/stcltm\/szad077","volume":"13","author":"A Al Madhoun","year":"2024","unstructured":"Al Madhoun A, et al. Clinical application of umbilical cord mesenchymal stem cells preserves beta-cells in type 1 diabetes. Stem Cells Transl Med. 2024;13(2):101\u201306.","journal-title":"STEM Cells Transl Med"},{"key":"7612_CR31","doi-asserted-by":"publisher","first-page":"732549","DOI":"10.3389\/fimmu.2021.732549","volume":"12","author":"MA Mrahleh","year":"2021","unstructured":"Mrahleh MA, et al. Human Wharton\u2019s jelly-derived mesenchymal stromal cells primed by tumor necrosis factor-alpha and interferon-gamma modulate the innate and adaptive immune cells of type 1 diabetic patients. Front Immunol. 2021;12:732549.","journal-title":"Front Immunol"},{"key":"7612_CR32","doi-asserted-by":"crossref","unstructured":"Perussolo MC, et al. Cellular therapy in experimental autoimmune encephalomyelitis as an adjuvant treatment to translate for multiple sclerosis. Int J Mol Sci. 2024;25(13).","DOI":"10.3390\/ijms25136996"},{"issue":"10","key":"7612_CR33","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3727\/096368914X685104","volume":"24","author":"R Donders","year":"2015","unstructured":"Donders R, et al. Human Wharton\u2019s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis. Cell Transpl. 2015;24(10):2077\u201398.","journal-title":"Cell Transpl"},{"issue":"2","key":"7612_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00403-022-02326-2","volume":"315","author":"MA Nilforoushzadeh","year":"2023","unstructured":"Nilforoushzadeh MA, et al. Promotion of cutaneous diabetic wound healing by subcutaneous administration of Wharton\u2019s jelly mesenchymal stem cells derived from umbilical cord. Arch Dermatol Res. 2023;315(2):147\u201359.","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"7612_CR35","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.1111\/jocd.15022","volume":"21","author":"MA Nilforoushzadeh","year":"2022","unstructured":"Nilforoushzadeh MA, et al. Topical spray of Wharton\u2019s jelly mesenchymal stem cells derived from umbilical cord accelerates diabetic wound healing. J Cosmet Dermatol. 2022;21(10):5156\u201367.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"7612_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/sctm.18-0273","volume":"9","author":"A Moreira","year":"2020","unstructured":"Moreira A, et al. Intranasal delivery of human umbilical cord Wharton\u2019s jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia. Stem Cells Transl Med. 2020;9(2):221\u201334.","journal-title":"STEM Cells Transl Med"},{"issue":"6","key":"7612_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1089\/scd.2019.0116","volume":"29","author":"M O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly M, et al. Late rescue therapy with cord-derived mesenchymal stromal cells for established lung injury in experimental bronchopulmonary dysplasia. Stem Cells Dev. 2020;29(6):364\u201371.","journal-title":"STEM Cells Dev"},{"issue":"3","key":"7612_CR38","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3892\/etm.2016.3544","volume":"12","author":"J Hu","year":"2016","unstructured":"Hu J, et al. Long term effect and safety of Wharton\u2019s jelly-derived mesenchymal stem cells on type 2 diabetes. Exp Ther Med. 2016;12(3):1857\u201366.","journal-title":"Exp Ther Med"},{"issue":"4","key":"7612_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/sctm.20-0308","volume":"10","author":"J Shim","year":"2021","unstructured":"Shim J, et al. Safety and efficacy of Wharton\u2019s jelly-derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: a phase I\/IIa study. Stem Cells Transl Med. 2021;10(4):554\u201367.","journal-title":"STEM Cells Transl Med"},{"issue":"2","key":"7612_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00441-023-03854-7","volume":"395","author":"MT Ashoobi","year":"2024","unstructured":"Ashoobi MT, et al. Wharton\u2019s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial. Cell Tissue Res. 2024;395(2):211\u201320.","journal-title":"Cell Tissue Res"},{"key":"7612_CR41","doi-asserted-by":"publisher","first-page":"1224865","DOI":"10.3389\/fmed.2023.1224865","volume":"10","author":"C Pochon","year":"2023","unstructured":"Pochon C, et al. Efficacy of Wharton jelly mesenchymal stromal cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial. Front Med (Lausanne). 2023;10:1224865.","journal-title":"Front Med (Lausanne)"},{"key":"7612_CR42","doi-asserted-by":"crossref","unstructured":"Malicev E, Jazbec K. An overview of mesenchymal stem cell heterogeneity and concentration. Pharmaceuticals (basel). 2024;17(3).","DOI":"10.3390\/ph17030350"},{"issue":"6","key":"7612_CR43","first-page":"437","volume":"44","author":"N Varaa","year":"2019","unstructured":"Varaa N, et al. Wharton\u2019s jelly mesenchymal stem cell: various protocols for isolation and differentiation of hepatocyte-like cells. Narrative Rev. Iran J Med Sci. 2019;44(6):437\u201348.","journal-title":"Narrative Rev. Iran J Med Sci"},{"issue":"1","key":"7612_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-024-03725-0","volume":"15","author":"W Chu","year":"2024","unstructured":"Chu W, et al. A GMP-compliant manufacturing method for Wharton\u2019s jelly-derived mesenchymal stromal cells. Stem Cell Res Ther. 2024;15(1):131.","journal-title":"STEM Cell Res Ther"},{"issue":"9","key":"7612_CR45","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.arthro.2015.03.014","volume":"31","author":"CT Vangsness","year":"2015","unstructured":"Vangsness CT, Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31(9):1836\u201343.","journal-title":"Arthroscopy"},{"issue":"4","key":"7612_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-3148.2011.01076.x","volume":"21","author":"N Tsagias","year":"2011","unstructured":"Tsagias N, et al. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfus Med. 2011;21(4):253\u201361.","journal-title":"Transfus Med"},{"issue":"12","key":"7612_CR47","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/trf.12743","volume":"54","author":"TK Chatzistamatiou","year":"2014","unstructured":"Chatzistamatiou TK, et al. Optimizing isolation culture and freezing methods to preserve Wharton\u2019s jelly\u2019s mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic cord blood Bank. Transfusion. 2014;54(12):3108\u201320.","journal-title":"Transfusion"},{"issue":"2","key":"7612_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1634\/stemcells.2006-0286","volume":"25","author":"S Karahuseyinoglu","year":"2007","unstructured":"Karahuseyinoglu S, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007;25(2):319\u201331.","journal-title":"STEM Cells"},{"issue":"5","key":"7612_CR49","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/BF02256131","volume":"11","author":"YS Fu","year":"2004","unstructured":"Fu YS, et al. Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci. 2004;11(5):652\u201360.","journal-title":"J Biomed Sci"},{"issue":"3","key":"7612_CR50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.rbmo.2010.04.010","volume":"21","author":"CY Fong","year":"2010","unstructured":"Fong CY, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton\u2019s jelly stem cells. Reprod Biomed Online. 2010;21(3):391\u2013401.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"7612_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sctm.19-0202","volume":"9","author":"M Kabat","year":"2020","unstructured":"Kabat M, et al. Trends in mesenchymal stem cell clinical trials 2004-2018: is efficacy optimal in a narrow dose range? STEM Cells Transl Med. 2020;9(1):17\u201327.","journal-title":"STEM Cells Transl Med"},{"key":"7612_CR52","doi-asserted-by":"publisher","first-page":"101744","DOI":"10.1016\/j.jcot.2021.101744","volume":"25","author":"S Muthu","year":"2022","unstructured":"Muthu S, et al. What is the clinically significant ideal mesenchymal stromal cell count in the management of osteoarthritis of the knee? - meta-analysis of randomized controlled trials. J Clin Orthop Trauma. 2022;25:101744.","journal-title":"J Clin Orthop Trauma"},{"issue":"8","key":"7612_CR53","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1097\/TP.0000000000001484","volume":"101","author":"DC Noriega","year":"2017","unstructured":"Noriega DC, et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;101(8):1945\u201351.","journal-title":"Transplantation"},{"issue":"5","key":"7612_CR54","doi-asserted-by":"publisher","first-page":"FSO794","DOI":"10.2144\/fsoa-2021-0155","volume":"8","author":"D Bates","year":"2022","unstructured":"Bates D, et al. Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study. Future Sci OA. 2022;8(5):FSO794.","journal-title":"Future Sci OA"},{"issue":"1","key":"7612_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cyto.a.23242","volume":"93","author":"D Mushahary","year":"2018","unstructured":"Mushahary D, et al. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018;93(1):19\u201331.","journal-title":"Cytometry A"},{"issue":"6","key":"7612_CR56","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.tiv.2014.12.008","volume":"29","author":"K Buyl","year":"2015","unstructured":"Buyl K, et al. Evaluation of a new standardized enzymatic isolation protocol for human umbilical cord-derived stem cells. Toxicol In Vitro. 2015;29(6):1254\u201362.","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"7612_CR57","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10616-012-9528-0","volume":"65","author":"YF Han","year":"2013","unstructured":"Han YF, et al. Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology. 2013;65(5):819\u201327.","journal-title":"Cytotechnology"},{"issue":"10","key":"7612_CR58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jcyt.2020.06.002","volume":"22","author":"ML Skiles","year":"2020","unstructured":"Skiles ML, et al. Comparison of umbilical cord tissue-derived mesenchymal stromal cells isolated from cryopreserved material and extracted by explantation and digestion methods utilizing a split manufacturing model. Cytotherapy. 2020;22(10):581\u201391.","journal-title":"Cytotherapy"},{"key":"7612_CR59","doi-asserted-by":"publisher","first-page":"428726","DOI":"10.1155\/2013\/428726","volume":"2013","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, et al. Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton\u2019s jelly. Biomed Res Int. 2013;2013:428726.","journal-title":"Biomed Res Int"},{"key":"7612_CR60","doi-asserted-by":"publisher","first-page":"963689722108435","DOI":"10.1177\/09636897221084354","volume":"31","author":"S Zheng","year":"2022","unstructured":"Zheng S, et al. A robust and highly efficient approach for isolation of mesenchymal stem cells from Wharton\u2019s jelly for tissue repair. Cell Transpl. 2022;31:9636897221084354.","journal-title":"Cell Transpl"},{"issue":"10","key":"7612_CR61","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.placenta.2004.10.008","volume":"26","author":"K Sobolewski","year":"2005","unstructured":"Sobolewski K, et al. Wharton\u2019s jelly as a reservoir of peptide growth factors. Placenta. 2005;26(10):747\u201352.","journal-title":"Placenta"},{"issue":"4","key":"7612_CR62","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10517-025-06369-z","volume":"178","author":"ES Kochetova","year":"2025","unstructured":"Kochetova ES, et al. Selection of optimal protocol for decellularization of extracellular matrix of mesenchymal stromal cells of human umbilical cord tissue. Bull Exp Biol Med. 2025;178(4):535\u201340.","journal-title":"Bull Exp Biol Med"},{"key":"7612_CR63","doi-asserted-by":"publisher","first-page":"828424","DOI":"10.3389\/fbioe.2022.828424","volume":"10","author":"M Dubus","year":"2022","unstructured":"Dubus M, et al. Decellularization of Wharton\u2019s jelly increases its bioactivity and antibacterial properties. Front Bioeng Biotechnol. 2022;10:828424.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"7612_CR64","doi-asserted-by":"publisher","first-page":"e0172098","DOI":"10.1371\/journal.pone.0172098","volume":"12","author":"S Jadalannagari","year":"2017","unstructured":"Jadalannagari S, et al. Decellularized Wharton\u2019s jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications. PLoS One. 2017;12(2):e0172098.","journal-title":"PLoS One"},{"key":"7612_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.msec.2017.04.074","volume":"78","author":"B Beiki","year":"2017","unstructured":"Beiki B, Zeynali B, Seyedjafari E. Fabrication of a three dimensional spongy scaffold using human Wharton\u2019s jelly derived extra cellular matrix for wound healing. Mater Sci Eng C Mater Biol Appl. 2017;78:627\u201338.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"7612_CR66","doi-asserted-by":"crossref","unstructured":"Ramzan F, et al. Decellularized human umbilical tissue-derived hydrogels promote proliferation and chondrogenic differentiation of mesenchymal stem cells. Bioeng (Basel). 2022;9(6).","DOI":"10.3390\/bioengineering9060239"},{"issue":"7","key":"7612_CR67","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jbm.a.37683","volume":"112","author":"L Penolazzi","year":"2024","unstructured":"Penolazzi L, et al. Wharton\u2019s jelly-derived multifunctional hydrogels: new tools to promote intervertebral disc regeneration in vitro and ex vivo. J Biomed Mater Res A. 2024;112(7):973\u201387.","journal-title":"J Biomed Mater Res A"},{"key":"7612_CR68","doi-asserted-by":"publisher","first-page":"rbaf037","DOI":"10.1093\/rb\/rbaf037","volume":"12","author":"C Wei","year":"2025","unstructured":"Wei C, et al. Enhancing the maturity of in vitro engineered cartilage from Wharton\u2019s jelly-derived photo-crosslinked hydrogel using dynamic bioreactors and its in vivo outcomes in animal models. Regen Biomater. 2025;12:rbaf037.","journal-title":"Regen Biomater"},{"issue":"Pt 1","key":"7612_CR69","doi-asserted-by":"publisher","first-page":"147552","DOI":"10.1016\/j.ijbiomac.2025.147552","volume":"328","author":"A Lavrand","year":"2025","unstructured":"Lavrand A, et al. Hydrogels from Wharton\u2019s jelly as alternative to conventional extracellular matrix-based constructs. Int J Biol Macromol. 2025;328(Pt 1):147552.","journal-title":"Int J Biol Macromol"},{"key":"7612_CR70","doi-asserted-by":"crossref","unstructured":"Tajbakhsh F, et al. Wharton\u2019s Jelly Hydrogel: an innovative artificial ovary for xenotransplantation of isolated human ovarian follicles. Biol (Basel). 2025;14(10).","DOI":"10.3390\/biology14101340"},{"issue":"Pt 6","key":"7612_CR71","doi-asserted-by":"publisher","first-page":"127128","DOI":"10.1016\/j.ijbiomac.2023.127128","volume":"253","author":"R Najafi","year":"2023","unstructured":"Najafi R, et al. Fabrication and optimization of multilayered composite scaffold made of sulfated alginate-based nanofiber\/decellularized Wharton\u2019s jelly ECM for tympanic membrane tissue engineering. Int J Biol Macromol. 2023;253(Pt 6):127128.","journal-title":"Int J Biol Macromol"},{"key":"7612_CR72","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.mtbio.2024.101258","volume":"29","author":"S Kang","year":"2024","unstructured":"Kang S, et al. Injectable decellularized Wharton\u2019s jelly hydrogel containing CD56(+) umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection. Mater Today Bio. 2024;29:101258.","journal-title":"Mater Today Bio"},{"key":"7612_CR73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/7651_2017_61","volume":"1577","author":"GL Converse","year":"2018","unstructured":"Converse GL, et al. Wharton\u2019s jelly matrix decellularization for tissue engineering applications. Methods Mol Biol. 2018;1577:25\u201333.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"7612_CR74","first-page":"3465","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Extracellular matrix deposited by Wharton\u2019s jelly mesenchymal stem cells enhances cell expansion and tissue specific lineage potential. Am J Transl Res. 2018;10(11):3465\u201380.","journal-title":"Am J Transl Res"},{"key":"7612_CR75","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fbioe.2020.00262","volume":"8","author":"L Penolazzi","year":"2020","unstructured":"Penolazzi L, et al. Extracellular matrix from Decellularized Wharton\u2019s jelly improves the behavior of cells from degenerated intervertebral disc. Front Bioeng Biotechnol. 2020;8:262.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"7612_CR76","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1002\/mabi.202400578","volume":"25","author":"Z Tavajjohi","year":"2025","unstructured":"Tavajjohi Z, et al. Therapeutic Performance of hydrogel-derived extracellular Wharton\u2019s jelly matrix and Wharton\u2019s jelly mesenchymal stem cells in repairing infarcted myocardium of ischemic rats: a preclinical study. Macromol Biosci. 2025;25(9):e70007.","journal-title":"Macromol Biosci"},{"issue":"10","key":"7612_CR77","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1002\/jcb.25563","volume":"117","author":"SB Shivakumar","year":"2016","unstructured":"Shivakumar SB, et al. DMSO- and serum-free cryopreservation of Wharton\u2019s jelly tissue isolated from human umbilical cord. J Cell Biochem. 2016;117(10):2397\u2013412.","journal-title":"J Cell Biochem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07612-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:02:42Z","timestamp":1771020162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07612-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7612"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07612-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This review was supported by TAM Global and Cellular Performance Institute. All authors are employees or consultants of TAM Global and\/or Cellular Performance Institute. The authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}